Key Events This Week
1 June: Intraday high of Rs.639.6 with a 7.39% gain
2 June: New 52-week and all-time high at Rs.663
3 June: New 52-week and all-time high at Rs.670.40, followed by a slight pullback
4 June: Modest gains with low volume
5 June: Closed week at Rs.676.10, up 2.24% on the day
Nephrocare Health Services Ltd Gains 10.92%: 7 Key Factors Driving the Surge
2026-06-13 09:00:58
Key Events This Week
8 Jun: New 52-week high at Rs.690.65 and all-time high at Rs.686.00
9 Jun: Multiple new highs including Rs.694.9 and intraday peak Rs.715.7 with 8.36% surge
10 Jun: New 52-week and all-time highs at Rs.725.15 and Rs.725.85
11 Jun: New 52-week high at Rs.760.85 and all-time high at Rs.760.50
12 Jun: New 52-week and all-time high at Rs.767.95, slight close dip of 0.19%

Nephrocare Health Services Ltd Hits All-Time High of Rs 767.95 as Momentum Builds Across Timeframes
2026-06-12 09:39:26After opening with a 2.01% gap up, Nephrocare Health Services Ltd touched a fresh all-time high of Rs 767.95 on 12 Jun 2026, marking a significant milestone in its recent rally despite a slight intraday pullback.
Read full news article
Broad-Based Technical Strength Lifts Nephrocare Health Services Ltd to 52-Week High of Rs 760.85
2026-06-11 15:37:41With a decisive surge to Rs 760.85 on 11 Jun 2026, Nephrocare Health Services Ltd has reached a fresh 52-week and all-time high, marking a significant milestone in its price momentum. This rally unfolds amid a broader market environment where the Sensex is retreating, underscoring the stock's relative strength and technical resilience.
Read full news articleClosure of Trading Window
19-Jun-2026 | Source : BSETrading window shall be closed till 48 hours from the declaration of the Unaudited Financial Results of the Company for the quarter ended June 30 2026.
Cancellation Of Scheduled Analyst / Institutional Investor Meetings
17-Jun-2026 | Source : BSEIn reference to our letter dated May 27 2026 regarding Analyst Meet has now been cancelled due to unavoidable exigencies as per disclosure annexed herewith.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
11-Jun-2026 | Source : BSEPursuant to Regulation 30 of the SEBI Listing Regulations we hereby inform you that the Company has scheduled an Investor Conference Call as per the disclosure enclosed herewith.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available











